David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 23,370 shares at $27.18 ($642K) on 2025-01-27, disclosed to the SEC on 2025-01-29.
Seasonal sale ($642k) by SVP, Life Sciences — this insider has traded PHR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.18 | 8,158 | $222K | 34.5% |
| 2 | $27.18 | 8,158 | $222K | 34.5% |
| 3 | $28.15 | 3,527 | $99K | 15.5% |
| 4 | $28.15 | 3,527 | $99K | 15.5% |
| Total | $27.47 avg | 23,370 | $642K | 100% |
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |